Development of Cell-Based Sentinels for Nitric Oxide: Ensuring Marker Expression and Unimodality.
Ryan McKayPricila HaukDavid QuanWilliam E BentleyPublished in: ACS synthetic biology (2018)
We generated "sentinel" bacteria that respond to the biomarker nitric oxide (NO) and produce a homogeneous and strong fluorescent response. Our dual-plasmid system consists of a signal "relay" vector that employs an NO-responsive promoter that amplifies the native signal (via expression of T7 Polymerase (T7Pol)) to a second vector responsible for GFP expression. Importantly, to achieve an optimal "sentinel" response, we developed strategies that balance the transcriptional load within cells by altering (i) translation and (ii) activity of the T7Pol. Our optimized genetic circuitry was then used to transform commensal E. coli Nissle, as a proof-of-concept toward an ingestible cell-based sensor for Crohn's disease (CD) that, in turn, is marked by elevated levels of intestinal NO. Thus, the "biosensors" demonstrated here may serve as a simple diagnostic tool, contrasting the standard of care including colonoscopies or biopsies.
Keyphrases
- nitric oxide
- poor prognosis
- escherichia coli
- single cell
- gene expression
- cell therapy
- healthcare
- transcription factor
- induced apoptosis
- binding protein
- dna methylation
- hydrogen peroxide
- stem cells
- nitric oxide synthase
- living cells
- long non coding rna
- crispr cas
- quality improvement
- quantum dots
- genome wide
- bone marrow
- cancer therapy
- cell death
- heat stress